Intensity Therapeutics Inc (NASDAQ: INTS) on Friday, soared 10.80% from the previous trading day, before settling in for the closing price of $0.46. Within the past 52 weeks, INTS’s price has moved between $0.19 and $3.17.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -23.29%. The company achieved an average annual earnings per share of 70.60%. With a float of $53.63 million, this company’s outstanding shares have now reached $60.06 million.
Intensity Therapeutics Inc (INTS) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Intensity Therapeutics Inc is 10.72%, while institutional ownership is 4.93%.
Intensity Therapeutics Inc (INTS) Performance Highlights and Predictions
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.22 earnings per share (EPS) for the period topping the consensus outlook (set at -0.23) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 70.60% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 40.02% during the next five years compared to -23.29% drop over the previous five years of trading.
Intensity Therapeutics Inc (NASDAQ: INTS) Trading Performance Indicators
Intensity Therapeutics Inc (INTS) is currently performing well based on its current performance indicators. A quick ratio of 3.60 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.63, a number that is poised to hit -0.05 in the next quarter and is forecasted to reach -0.21 in one year’s time.
Technical Analysis of Intensity Therapeutics Inc (INTS)
The latest stats from [Intensity Therapeutics Inc, INTS] show that its last 5-days average volume of 5.41 million was inferior to 9.68 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 80.88%.
During the past 100 days, Intensity Therapeutics Inc’s (INTS) raw stochastic average was set at 20.89%, which indicates a significant decrease from 88.83% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0448 in the past 14 days, which was lower than the 0.0503 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3830, while its 200-day Moving Average is $0.7315. Now, the first resistance to watch is $0.5333. This is followed by the second major resistance level at $0.5567. The third major resistance level sits at $0.5833. If the price goes on to break the first support level at $0.4833, it is likely to go to the next support level at $0.4567. Assuming the price breaks the second support level, the third support level stands at $0.4333.
Intensity Therapeutics Inc (NASDAQ: INTS) Key Stats
Market capitalization of the company is 30.63 million based on 60,065K outstanding shares. Right now, sales total 0 K and income totals -16,270 K. The company made 0 K in profit during its latest quarter, and -2,670 K in sales during its previous quarter.
